高级检索
当前位置: 首页 > 详情页

Polymorphisms in the promoter regions of the matrix metalloproteinases-1,-3,-7, and-9 and the risk of epithelial ovarian cancer in China

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Hebei Cancer Institute, Hebei Medical University, Jiankanglu 12, Shijiazhuang 050011, Hebei Province, China [2]The Fourth Affiliated Hospital, Hebei Medical University, Shijiazhuang 050011, Hebei Province, China
出处:
ISSN:

关键词: matrix metalloproteinase-1 -3 -7 -9 single nucleotide polymorphism epithelium ovarian cancer polymerase chain reaction restriction fragment length polymorphism

摘要:
Purpose. To investigate the association of single nucleotide polymorphisms (SNP) in the promoter region of the matrix metalloproteinases-1 -1607bp1G/2G, matrix metalloproteinases-3 -1171bp5A/6A, matrix metalloproteinases-7 A-181G and matrix metalloproteinases-9 C-1562T with susceptibility to ovarian cancer in a population of North China. Experimental design. We analyzed four different functional promoter polymorphisms in the respective genes by polymerase chain reaction (PCR)restriction fragment length polymorphism (RFLP) in a sample of patients with epithelium ovarian cancer and control women, all from North China. Results. No significant difference was detected between the patient and control groups in genotype and allelotype distribution of MMP-1, MMP-3, MMP-9 of the polymorphisms studied. However, the genotype and allelotype of the MMP-7 distribution in ovarian cancer patients were significantly different from that in healthy controls. The frequency of the -181G allele of MMP-7 in patients was significantly higher than that in healthy controls women (8.2% vs. 2.8%, P = 0.002). Compared to the A/A genotype, the genotypes with the -181 G allele (A/G + G/G) significantly increased susceptibility to ovarian cancer, with adjusted odds ratio [OR] = 3.53 95% confidence interval [CI] [1.58 to 7.89]. Conclusions. The study suggested that a possible association between the MMP-7 A/G polymorphism with susceptibility to epithelium ovarian cancer, but there is no support for an association of the selected MMP-1 1G/2G, MMP-3 5A/6A, and MMP-9 C/T polymorphisms with the risk for ovarian cancer. (C) 2005 Elsevier Inc. All rights reserved.

语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2006]版:
大类 | 3 区 医学
最新[2025]版:
大类 | 2 区 医学
小类 | 1 区 妇产科学 2 区 肿瘤学
JCR分区:
出版当年[2006]版:
Q1 OBSTETRICS & GYNECOLOGY Q3 ONCOLOGY
最新[2024]版:
Q1 OBSTETRICS & GYNECOLOGY Q2 ONCOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2006版] 出版当年五年平均 出版前一年[2005版] 出版后一年[2007版]

第一作者:
第一作者机构: [1]Hebei Cancer Institute, Hebei Medical University, Jiankanglu 12, Shijiazhuang 050011, Hebei Province, China
通讯作者:
通讯机构: [1]Hebei Cancer Institute, Hebei Medical University, Jiankanglu 12, Shijiazhuang 050011, Hebei Province, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42329 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号